Shionogi’s oral antiviral for respiratory syncytial virus (RSV) has met its primary endpoint in a Phase II study that saw ...

Lower rates of both progression of macular fibrosis and intravitreal aflibercept injections were found in those who used the ...

Sanofi said it will repurchase €5 billion ($5.2 billion) of stock and grow profits faster this year as the drugmaker pivots ...

Shionogi’s respiratory syncytial virus (RSV) antiviral for adults has proven its ability to reduce viral load in a phase 2 ...

Eleven drugs are poised to reach blockbuster status, dramatically improving patient outcomes on a global scale.

RSV is usually contagious for three to eight days. A patient also may be contagious a day or two before experiencing symptoms ...

FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.

During cold and flu season, it can be challenging to differentiate illnesses like the common cold, flu, COVID-19, respiratory ...

Human Metapneumovirus (HMPV) is a respiratory virus that may not be on most folk’s radars, but it’s more common than you ...

The Health Department of Northwest Michigan is reporting an increase in respiratory illnesses across Antrim, Charlevoix, ...

It spreads through inhalation or contact with the fluids from an infected person's coughs or sneezes. 2 While often linked to ...